Cytokinetics Secures $700M in Upsized Share Sale at $71 Each
The biopharmaceutical firm raises $700M through an expanded equity offering priced at $71 per share. Cytokinetics completed an upsized equity offering, raising $700M by selling shares at $71 each. The move expands the company’s capital base amid ongoing drug development an